f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", |
| "groups": [], | | "groups": [], |
| "id": "3bf17018-14dc-4e30-89c3-dc238af815e3", | | "id": "3bf17018-14dc-4e30-89c3-dc238af815e3", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2022-07-24T14:51:14.256616", | | "metadata_created": "2022-07-24T14:51:14.256616", |
n | "metadata_modified": "2022-07-24T14:54:03.302274", | n | "metadata_modified": "2022-07-24T14:55:54.384624", |
| "name": "malawi-integrated-hiv-program-report-2020-q3", | | "name": "malawi-integrated-hiv-program-report-2020-q3", |
| "notes": "# Executive Summary (July-September 2020)\r\n__COVID-19 | | "notes": "# Executive Summary (July-September 2020)\r\n__COVID-19 |
n | Disruptions to the HIV Program__\r\nThe first cases of COVID-19 in | n | Disruptions to the HIV Program__\r\n\r\nThe first cases of COVID-19 in |
| Malawi were confirmed on 2nd April 2020 and early epidemiological | | Malawi were confirmed on 2nd April 2020 and early epidemiological |
| models predicted rapid spread and severe impact of COVID-19 in | | models predicted rapid spread and severe impact of COVID-19 in |
| Malawi.\r\n\r\nThe DHA issued 3 editions of a circular to all HIV | | Malawi.\r\n\r\nThe DHA issued 3 editions of a circular to all HIV |
| service delivery sites (on 3rd, 17th April and 15th June) with | | service delivery sites (on 3rd, 17th April and 15th June) with |
| specific infection prevention guidance for COVID-19, and policy | | specific infection prevention guidance for COVID-19, and policy |
| recommendations aimed at decongesting facilities, and reducing travel | | recommendations aimed at decongesting facilities, and reducing travel |
| and contact exposure for patients and health workers. This included a | | and contact exposure for patients and health workers. This included a |
| temporary suspension of non-essential\r\nservices: routine scheduled | | temporary suspension of non-essential\r\nservices: routine scheduled |
| viral load monitoring for stable adult patients; VMMC; active index | | viral load monitoring for stable adult patients; VMMC; active index |
| partner tracing; new initiation of IPT and PrEP; Teen clubs and other | | partner tracing; new initiation of IPT and PrEP; Teen clubs and other |
| ART support groups involving social gatherings. The DHA also | | ART support groups involving social gatherings. The DHA also |
| recommended an enhanced implementation of 6-month ARV dispensing for | | recommended an enhanced implementation of 6-month ARV dispensing for |
| almost all patient groups. As the COVID-19 impact remained much lower | | almost all patient groups. As the COVID-19 impact remained much lower |
| than initially feared, the suspended services were successively | | than initially feared, the suspended services were successively |
| reintroduced.\r\n\r\nAccess to most HIV services recovered slightly | | reintroduced.\r\n\r\nAccess to most HIV services recovered slightly |
| during Q3 as COVID case numbers remained low during Q3 2020 but it | | during Q3 as COVID case numbers remained low during Q3 2020 but it |
| remained below targets and lower than in the pre-COVID | | remained below targets and lower than in the pre-COVID |
| period.\r\n\r\n__Scale-up of integrated Program performance highlights | | period.\r\n\r\n__Scale-up of integrated Program performance highlights |
t | by the end of June 2020__\r\n* Scale-up of integrated HIV services had | t | by the end of June 2020__\r\n\r\n* Scale-up of integrated HIV services |
| reached the following number of sites:\r\n * __763__ static and | | had reached the following number of sites:\r\n * __763__ static |
| __104__ outreach HIV testing sites.\r\n * __754__ (static) ART | | and __104__ outreach HIV testing sites.\r\n * __754__ (static) |
| sites; __604__ of these started at least one pregnant or breastfeeding | | ART sites; __604__ of these started at least one pregnant or |
| woman.\r\n * __698__ sites with HIV-exposed children in | | breastfeeding woman.\r\n * __698__ sites with HIV-exposed |
| follow-up.\r\n* __697,991__ persons were tested for HIV and received | | children in follow-up.\r\n* __697,991__ persons were tested for HIV |
| their results; __117,885 (17%)__ accessed HIV testing for the first | | and received their results; __117,885 (17%)__ accessed HIV testing for |
| time; __580,106 (83%)__ were repeat testers and __22,638 (4%)__ of | | the first time; __580,106 (83%)__ were repeat testers and __22,638 |
| these received confirmatory testing (after having tested positive in | | (4%)__ of these received confirmatory testing (after having tested |
| the past). __20,206 (3.0%)__ clients received a positive result for | | positive in the past). __20,206 (3.0%)__ clients received a positive |
| the first time.\r\n* A total of __108,030__ people received | | result for the first time.\r\n* A total of __108,030__ people received |
| __186,485__ self-test kits for either primary or secondary use.\r\n* | | __186,485__ self-test kits for either primary or secondary use.\r\n* |
| __16,164 (95%)__ of __16,961__ blood units collected were screened for | | __16,164 (95%)__ of __16,961__ blood units collected were screened for |
| (at least) HIV, hepatitis B and syphilis.\r\n* __155,128 (99%)__ of | | (at least) HIV, hepatitis B and syphilis.\r\n* __155,128 (99%)__ of |
| 158,524 women at ANC had their HIV status ascertained; __10,253 (7%)__ | | 158,524 women at ANC had their HIV status ascertained; __10,253 (7%)__ |
| of these were HIV positive. __138,044 (94%)__ of __147,191__ at | | of these were HIV positive. __138,044 (94%)__ of __147,191__ at |
| maternity had their HIV status ascertained __10,190 (7%)__ of these | | maternity had their HIV status ascertained __10,190 (7%)__ of these |
| were HIV positive.\r\n* __19,384__ patients started ART this quarter; | | were HIV positive.\r\n* __19,384__ patients started ART this quarter; |
| __78%__ were classified as asymptomatic / in WHO stage 1 and started | | __78%__ were classified as asymptomatic / in WHO stage 1 and started |
| under the \u201cTest & Treat\u201d policy.", | | under the \u201cTest & Treat\u201d policy.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 9, | | "num_tags": 9, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-07-24T14:54:03.109206", | | "created": "2022-07-24T14:54:03.109206", |
| "description": "Malawi Integrated HIV Program Report for | | "description": "Malawi Integrated HIV Program Report for |
| July-September 2020", | | July-September 2020", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "486c21cf-8402-423d-9635-4246469ac664", | | "id": "486c21cf-8402-423d-9635-4246469ac664", |
| "last_modified": "2022-07-24T14:54:03.046839", | | "last_modified": "2022-07-24T14:54:03.046839", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2020-q3", | | "dha/malawi-integrated-hiv-program-report-2020-q3", |
| "metadata_modified": "2022-07-24T14:54:03.307568", | | "metadata_modified": "2022-07-24T14:54:03.307568", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "Malawi Integrated HIV Program Report 2020 Q3", | | "name": "Malawi Integrated HIV Program Report 2020 Q3", |
| "package_id": "3bf17018-14dc-4e30-89c3-dc238af815e3", | | "package_id": "3bf17018-14dc-4e30-89c3-dc238af815e3", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "955e16a87e0b165e4a2c6b93a9a199733b2e2084ee3aa22cc590d6d648b2c56e", | | "955e16a87e0b165e4a2c6b93a9a199733b2e2084ee3aa22cc590d6d648b2c56e", |
| "size": 5067802, | | "size": 5067802, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| 46469ac664/download/malawi_integrated_hiv_program_report_2020-q3.pdf", | | 46469ac664/download/malawi_integrated_hiv_program_report_2020-q3.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "HTC", | | "display_name": "HTC", |
| "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", | | "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", |
| "name": "HTC", | | "name": "HTC", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "PMTCT-ART", | | "display_name": "PMTCT-ART", |
| "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", | | "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", |
| "name": "PMTCT-ART", | | "name": "PMTCT-ART", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "STI", | | "display_name": "STI", |
| "id": "94fb1475-9b2d-40af-b19d-c6463a0dd66d", | | "id": "94fb1475-9b2d-40af-b19d-c6463a0dd66d", |
| "name": "STI", | | "name": "STI", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "anc", | | "display_name": "anc", |
| "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", |
| "name": "anc", | | "name": "anc", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "art", | | "display_name": "art", |
| "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", | | "id": "ab255b9d-6d35-4789-8ce0-ce10bbe1e299", |
| "name": "art", | | "name": "art", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "blood safety", | | "display_name": "blood safety", |
| "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", |
| "name": "blood safety", | | "name": "blood safety", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "hiv", | | "display_name": "hiv", |
| "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", |
| "name": "hiv", | | "name": "hiv", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "maternity", | | "display_name": "maternity", |
| "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", |
| "name": "maternity", | | "name": "maternity", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "viral load", | | "display_name": "viral load", |
| "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", |
| "name": "viral load", | | "name": "viral load", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2020 Q3", | | "title": "Malawi Integrated HIV Program Report 2020 Q3", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2022" | | "year": "2022" |
| } | | } |